Heterozygous Pkhd1C642* mice develop cystic liver disease and proximal tubule ectasia that mimics radiographic signs of medullary sponge kidney
Authors:
- 1 March 2019
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 316 (3) , F463-F472
Abstract
Heterozygosity for human polycystic kidney and hepatic disease 1 ( PKHD1) mutations was recently associated with cystic liver disease and radiographic findings resembling medullary sponge kidney (MSK). However, the relevance of these associations has been tempered by a lack of cystic liver or renal disease in heterozygous mice carrying Pkhd1 gene trap or exon deletions. To determine whether heterozygosity for a smaller Pkhd1 defect can trigger cystic renal disease in mice, we generated and characterized mice with the predicted truncating Pkhd1C642* mutation in a region corresponding to the middle of exon 20 cluster of five truncating human mutations (between PKHD1G617fs and PKHD1G644*). Mouse heterozygotes or homozygotes for the Pkhd1C642* mutation did not have noticeable liver or renal abnormalities on magnetic resonance images during their first weeks of life. However, when aged to ~1.5 yr, the Pkhd1C642* heterozygotes developed prominent cystic liver changes; tissue analyses revealed biliary cysts and increased number of bile ducts without signs of congenital hepatic fibrosis-like portal field inflammation and fibrosis that was seen in Pkhd1C642* homozygotes. Interestingly, aged female Pkhd1C642* heterozygotes, as well as homozygotes, developed radiographic changes resembling MSK. However, these changes correspond to proximal tubule ectasia, not an MSK-associated collecting duct ectasia. In summary, by demonstrating that cystic liver and kidney abnormalities are triggered by heterozygosity for the Pkhd1C642* mutation, we provide important validation for relevant human association studies. Together, these investigations indicate that PKHD1 mutation heterozygosity (predicted frequency 1 in 70 individuals) is an important underlying cause of cystic liver disorders and MSK-like manifestations in a human population.Keywords
Funding Information
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (P30-DK-074038, DK097423, P30-DK-079337)
- U.S. Department of Veterans Affairs (VA) (1-I01-BX002298)
- Detraz Endowed Research Fund
This publication has 18 references indexed in Scilit:
- Biopsy Proven Medullary Sponge Kidney: Clinical Findings, Histopathology, and Role of Osteogenesis in Stone and Plaque FormationThe Anatomical Record, 2015
- Intragenic motifs regulate the transcriptional complexity of Pkhd1/PKHD1Journal of Molecular Medicine, 2014
- Hepatorenal findings in obligate heterozygotes for autosomal recessive polycystic kidney diseaseMolecular Genetics and Metabolism, 2011
- Renal CD14 expression correlates with the progression of cystic kidney diseaseKidney International, 2010
- Kidney cysts, pancreatic cysts, and biliary disease in a mouse model of autosomal recessive polycystic kidney diseasePediatric Nephrology, 2008
- Tandem mass spectrometry measurements of creatinine in mouse plasma and urine for determining glomerular filtration rateKidney International, 2007
- Mouse Models in Aging Research2007
- A mouse model for cystic biliary dysgenesis in autosomal recessive polycystic kidney disease (ARPKD)†Hepatology, 2005
- PKHD1mutations in families requesting prenatal diagnosis for autosomal recessive polycystic kidney disease (ARPKD)Human Mutation, 2004
- PKHD1mutations in autosomal recessive polycystic kidney disease (ARPKD)Human Mutation, 2004